180 related articles for article (PubMed ID: 30193046)
1. [THE ROLE OF AUTOANTIBODIES TO THE EXTRACELLULAR REGIONS OF IONOTROPIC RECEPTORS IN ETIOLOGY AND PATHOGENESIS OF AUTOIMMUNE DISEASES].
Zharova OA; Shpakov AO
Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):773-91. PubMed ID: 30193046
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune channelopathies in paraneoplastic neurological syndromes.
Joubert B; Honnorat J
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
[TBL] [Abstract][Full Text] [Related]
3. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review.
Wei YC; Huang CC; Liu CH; Kuo HC; Lin JJ
Brain Behav; 2017 Sep; 7(9):e00779. PubMed ID: 28948076
[TBL] [Abstract][Full Text] [Related]
5. [Pathology of paraneoplastic syndromes of the central and peripheral nervous systems and muscle ].
Ferrer I
Rev Neurol; 2000 Dec 16-31; 31(12):1228-36. PubMed ID: 11211860
[TBL] [Abstract][Full Text] [Related]
6. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua.
Takahashi Y; Mori H; Mishina M; Watanabe M; Kondo N; Shimomura J; Kubota Y; Matsuda K; Fukushima K; Shiroma N; Akasaka N; Nishida H; Imamura A; Watanabe H; Sugiyama N; Ikezawa M; Fujiwara T
Epilepsia; 2005; 46 Suppl 5():152-8. PubMed ID: 15987271
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
[TBL] [Abstract][Full Text] [Related]
9. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
[TBL] [Abstract][Full Text] [Related]
10. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.
Takahashi Y; Mori H; Mishina M; Watanabe M; Fujiwara T; Shimomura J; Aiba H; Miyajima T; Saito Y; Nezu A; Nishida H; Imai K; Sakaguchi N; Kondo N
Neurology; 2003 Oct; 61(7):891-6. PubMed ID: 14557555
[TBL] [Abstract][Full Text] [Related]
13. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases.
Nossal GJ
Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669
[No Abstract] [Full Text] [Related]
14. Genetics of childhood disorders: XXX. Autoimmune disorders, part 3: myasthenia gravis and Rasmussen's encephalitis.
Lombroso PJ; Mercadante MT
J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1115-7. PubMed ID: 11556637
[No Abstract] [Full Text] [Related]
15. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
16. [Newly discovered autoimmune encephalitis wrongly mistaken for mental disease. Anti-NMDA receptor encephalitis puts demands on correct differential diagnosis].
Piehl F; Winnerbäck K
Lakartidningen; 2010 Mar 3-9; 107(9):589-91. PubMed ID: 20387757
[No Abstract] [Full Text] [Related]
17. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
Iizuka T; Sakai F
Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis.
Buenz EJ; Howe CL
Can J Neurol Sci; 2007 Feb; 34(1):108-9. PubMed ID: 17352358
[No Abstract] [Full Text] [Related]
19. Antibodies to AMPA receptors in Rasmussen's encephalitis.
Nibber A; Clover L; Pettingill P; Waters P; Elger CE; Bien CG; Vincent A; Lang B
Eur J Paediatr Neurol; 2016 Mar; 20(2):222-227. PubMed ID: 26785913
[TBL] [Abstract][Full Text] [Related]
20. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
